These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8498881)

  • 61. Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS).
    Dhar V; Murphy BE
    Psychoneuroendocrinology; 1990; 15(5-6):489-93. PubMed ID: 1966304
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group.
    Magill PJ
    Br J Gen Pract; 1995 Nov; 45(400):589-93. PubMed ID: 8554838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
    J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.
    Pecknold J; Luthe L; Munjack D; Alexander P
    J Clin Psychopharmacol; 1994 Oct; 14(5):314-21. PubMed ID: 7806686
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of low progesterone and tension as triggers of perimenstrual chocolate and sweets craving: some negative experimental evidence.
    Michener W; Rozin P; Freeman E; Gale L
    Physiol Behav; 1999 Sep; 67(3):417-20. PubMed ID: 10497961
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
    Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K; Chung HR; Csanalosi IB; Hurowitz AM; London J; Wiseman K; Kaplan M; Amsterdam JD
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    Sato A; Fukawa-Nagira A; Sashihara T
    Nutrients; 2023 Dec; 15(23):. PubMed ID: 38068843
    [No Abstract]   [Full Text] [Related]  

  • 71. Naproxen sodium in the treatment of premenstrual symptoms. A placebo-controlled study.
    Facchinetti F; Fioroni L; Sances G; Romano G; Nappi G; Genazzani AR
    Gynecol Obstet Invest; 1989; 28(4):205-8. PubMed ID: 2695413
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progesterone and the premenstrual syndrome: a double blind crossover trial.
    Dennerstein L; Spencer-Gardner C; Gotts G; Brown JB; Smith MA; Burrows GD
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1617-21. PubMed ID: 3924191
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome.
    London RS; Murphy L; Kitlowski KE; Reynolds MA
    J Reprod Med; 1987 Jun; 32(6):400-4. PubMed ID: 3302248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E; Rickels K; Weiss S; Zavodnick S
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment.
    Braun P; Greenberg D; Dasberg H; Lerer B
    J Clin Psychiatry; 1990 Jun; 51(6):236-8. PubMed ID: 2189869
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome.
    Vellacott ID; Shroff NE; Pearce MY; Stratford ME; Akbar FA
    Curr Med Res Opin; 1987; 10(7):450-6. PubMed ID: 3621990
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
    Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
    Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
    Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
    Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bromocriptine (Bromergon, Lek) in the management of premenstrual syndrome.
    Meden-Vrtovec H; Vujić D
    Clin Exp Obstet Gynecol; 1992; 19(4):242-8. PubMed ID: 1294345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.